Lobectomy in patients with differentiated thyroid cancer: experience of a Chilean tertiary center

被引：0

作者：

Fuentes, Ignacio ^{[1
,2
]}

Santana, Roberto ^{[1
]}

Espinoza, Martin ^{[1
]}

Arteaga, Eugenio ^{[1
,2
]}

Uslar, Thomas ^{[1
,2
]}

Baudrand, Rene ^{[1
,2
]}

Gonzalez, Gilberto ^{[1
,2
]}

Guarda, Francisco J. ^{[1
,2
]}

Lustig, Nicole ^{[1
,2
]}

Mosso, Lorena ^{[1
,2
]}

Nilo, Flavia ^{[1
,2
]}

Valenzuela, Felipe ^{[1
,2
]}

Dominguez, Francisco ^{[3
]}

Gonzalez, Hernan Eugenio ^{[3
]}

Montero, Pablo H. ^{[3
]}

Cruz, Francisco ^{[4
]}

Solar, Antonieta ^{[5
]}

Dominguez, Jose M. ^{[1
,2
]}

机构：

[1] Pontificia Univ Catolica Chile, Fac Med, Dept Endocrinol, Santiago, Chile

[2] Pontificia Univ Catolica Chile, Fac Med, CETREN UC, Santiago, Chile

[3] Pontificia Univ Catolica Chile, Fac Med, Dept Head & Neck Surg, Santiago, Chile

[4] Pontificia Univ Catolica Chile, Fac Med, Dept Radiol, Santiago, Chile

[5] Pontificia Univ Catolica Chile, Fac Med, Dept Pathol, Santiago, Chile

来源：

ENDOCRINE | 2024年 / 86卷 / 02期

关键词：

Thyroid cancer; Lobectomy; Anti thyroglobulin antibodies; Quality of Life; Personalized medicine; MANAGEMENT GUIDELINES; RISK; WELL; HEMITHYROIDECTOMY; COMPLICATIONS; RADIOIODINE; CARCINOMA; EXTENSION; SURVIVAL; NODULES;

D O I：

10.1007/s12020-024-03905-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PurposeThyroid lobectomy (TL) is an appropriate treatment for up to 4 cm intrathyroidal differentiated thyroid cancer (DTC). There is scarce data regarding TL outside first-world centers. Our aim is to report a cohort of patients with DTC treated with TL in Chile.MethodsWe included DTC patients treated with TL, followed for at least 6 months, characterized their clinicopathological features and classified their risk of recurrence and response to treatment.ResultsEighty-two patients followed for a median of 2.3 years (0.5-7.0). Seventy-three (89%) patients had papillary, 8 (9.8%) follicular and 1 (1.2%) high-grade DTC. The risk of recurrence was low in 56 (68.3%) and intermediate in 26 (31.7%). Eight (9.8%) patients required early completion thyroidectomy and radioiodine. At last follow-up, 52 (70.3%) had excellent, 19 (25.7%) had indeterminate, and 1 (1.4%) had structural incomplete response.ConclusionIn a developing country, TL is an adequate option for appropriately selected DTC patients.

引用

页码：692 / 698

页数：7

共 43 条

[1] Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer [J].

Al-Qurayshi, Zaid ;

Shama, Mohamed A. ;

Randolph, Gregory W. ;

Kandil, Emad .

[2] OVERALL AND CAUSE-SPECIFIC SURVIVAL FOR PATIENTS UNDERGOING LOBECTOMY, NEAR-TOTAL, OR TOTAL THYROIDECTOMY FOR DIFFERENTIATED THYROID CANCER [J].

Barney, Brandon M. ;

Hitchcock, Ying J. ;

Sharma, Pramod ;

Shrieve, Dennis C. ;

Tward, Jonathan D. .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (05) :645-649

[3] Extent of surgery affects survival for papillary thyroid cancer [J].

Bilimoria, Karl Y. ;

Bentrem, David J. ;

Ko, Clifford Y. ;

Stewart, Andrew K. ;

Winchester, David P. ;

Talamonti, Mark S. ;

Sturgeon, Cord .

ANNALS OF SURGERY, 2007, 246 (03) :375-384

[4] Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma [J].

Bongers, Pim J. ;

Greenberg, Caylee A. ;

Hsiao, Ralph ;

Vermeer, Marloes ;

Vriens, Menno R. ;

Holzik, Martijn F. Lutke ;

Goldstein, David P. ;

Devon, Karen ;

Rotstein, Lorne E. ;

Sawka, Anna M. ;

Pasternak, Jesse D. .

SURGERY, 2020, 167 (01) :94-100

[5] Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer [J].

Chan, Samuel ;

Karamali, Katarina ;

Kolodziejczyk, Anna ;

Oikonomou, Georgios ;

Watkinson, John ;

Paleri, Vinidh ;

Nixon, Iain ;

Kim, Dae .

EUROPEAN THYROID JOURNAL, 2020, 9 (02) :73-84

[6] Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients [J].

Cho, Jae Won ;

Lee, Yu-mi ;

Lee, Yi Ho ;

Hong, Suck Joon ;

Yoon, Jong Ho .

CLINICAL ENDOCRINOLOGY, 2018, 89 (01) :100-109

[7] Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement? [J].

Durante, Cosimo ;

Montesano, Teresa ;

Attard, Marco ;

Torlontano, Massimo ;

Monzani, Fabio ;

Costante, Giuseppe ;

Meringolo, Domenico ;

Ferdeghini, Marco ;

Tumino, Salvatore ;

Lamartina, Livia ;

Paciaroni, Alessandra ;

Massa, Michela ;

Giacomelli, Laura ;

Ronga, Giuseppe ;

Filetti, Sebastiano .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (08) :2748-2753

[8] In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation [J].

Felipe Zavala, Luis ;

Ines Barra, Maria ;

Olmos, Roberto ;

Tuttle, Michael ;

Gonzalez, Hernan ;

Droppelmann, Nicolas ;

Mosso, Lorena ;

Dominguez, Jose M. .

ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2019, 63 (03) :293-299

[9] Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis [J].

Giovanella, Luca ;

Ceriani, Luca ;

Garo, Maria Luisa .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (07) :1091-1100

[10] Completion Thyroidectomy: Safer than Thought [J].

Gulcelik, Mehmet A. ;

Dogan, Lutfi ;

Guven, H. Erhan ;

Akgul, Gokhan G. ;

Gulcelik, Nese Ersoz .

ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (06) :386-390

← 1 2 3 4 5 →